Journal:Acta Cryst F:S2053230X24010094
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
2. Regulatory Mechanisms: Our structural analysis sheds light on the functional implications of SB505124 binding, particularly its role in disrupting TGF-β signaling pathways, which are often deregulated in various cancers. | 2. Regulatory Mechanisms: Our structural analysis sheds light on the functional implications of SB505124 binding, particularly its role in disrupting TGF-β signaling pathways, which are often deregulated in various cancers. | ||
3. Therapeutic Potential: Based on our structural findings, we discuss the potential of SB505124 as a therapeutic agent in cancer treatment, providing a foundation for future drug development efforts targeting TGFβR1. | 3. Therapeutic Potential: Based on our structural findings, we discuss the potential of SB505124 as a therapeutic agent in cancer treatment, providing a foundation for future drug development efforts targeting TGFβR1. | ||
| + | <br> | ||
| + | <scene name='10/1060550/007_Fig_3/1'>007_Fig_3</scene> | ||
<b>References</b><br> | <b>References</b><br> | ||
Revision as of 08:59, 10 November 2024
| |||||||||||
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
